Awardee: Mark Dunne
Institution: University of Manchester
Award Amount: $71,000
Funding Period: January 1, 2016 - December 31, 2016
Towards Precision Medicine in the Treatment of Congenital Hyperinsulinism in Infancy
Previous
Previous
Optimizing Delivery and Endpoints of an AAV9-mediated Gene Therapy Trial in AMN
Next
Next